Follow-up of the T-cell clonality in Sezary patients treated by extracorporeal photopheresis using a new assay: The immunoscope technique

Transfusion and Apheresis Science

Volumn 28, Issue 1, 2003, Pages 35-42

  Ingen Housz Oro, Saskia ^a,b   Bussel, Annette ^a   Flageul, Béatrice ^a   Dubertret, Louis ^a   Michel, Laurence ^a   Gachelin, Gabriel ^b   Kourilsky, Philippe ^b   Bachelez, Hervé ^a   Musette, Philippe ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Extracorporeal photopheresis; Sezary syndrome; T cell clone

Indexed keywords

METHOXSALEN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOSCOPY; MALE; PUVA; REMISSION; SEZARY SYNDROME; T LYMPHOCYTE; TUMOR CELL CULTURE; ULTRAVIOLET A RADIATION;

EID: 0037294727     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-0502(02)00098-8     Document Type: Article

References (28)

1. Edelson R., Berger C., Gasparro F.et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N. Engl. J. Med. 316:1987;297-303.
2. Fraser-Andrews E., Seed P., Whittaker S.et al. Extracorporeal photopheresis in Sezary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone. Arch. Dermatol. 134:1998;1001-1005.
3. Gottlieb S.L., Wolfe J.T., Fox F.E.et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10 years experience at a single institution. J. Am. Acad. Dermatol. 35:1996;946-957.
4. Dippel E., Schrag H., Goerdt D.et al. Extracorporeal photopheresis and interferon-alfa in advanced cutaneous T-cell lymphoma. Lancet. 350:1997;32-33.
5. Rook A.H., Prystowsky M.B., Cassin M.et al. Combined therapy for Sezary syndrome with extracorporeal photochemotherapy and low-dose interferon-alfa therapy. Clinical, molecular, and immunologic observations. Arch. Dermatol. 127:1991;1535-1540.
6. Smith N.P., Mountford L., Hamblin A.et al. Treatment of Sezary syndrome with extracorporeal photochemotherapy. Transfus. Sci. 15:1994;439-441.
7. Curco N., Servitje O., Llucia M.et al. Genotypic analysis of cutaneous T-cell lymphoma: a comparative study of southern blot analysis with polymerase chain reaction of the T-cell receptor g gene. Br. J. Dermatol. 137:1997;673-679.
8. Wood G.S., Tung R., Haeffner A.C.et al. Detection of clonal T-cell receptor. γ gene rearrengement in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE) J. Invest. Dermatol. 103:1994;34-41.
9. Meyer J.C., Hassam S., Dummer R.et al. A realistic approach to the sensitivity of PCR-DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T-cell proliferations. Exp. Dermatol. 6:1997;122-127.
10. Witzens M., Mohler T., Willhauck M.et al. Detection of clonaly rearrenged T-cell receptor gamma chain genes from T-cell malignancies and acute inflammatory rheumatic disease using PCR amplification, PAGE, and automated analysis. Ann. Hematol. 74:1997;123-130.
11. Guitard J., Kaul K. A new polymerase chain reaction based method for detection of T-cell clonality in patients with possible cutaneous T-cell lymphoma. Arch. Dermatol. 135:1999;158-162.
12. Gorochov G., Bachelez H., Cayuela J.M.et al. Expresion of Vβ gene segments by Sezary cells. J. Invest. Dermatol. 105:1995;56-61.
13. Thor P., Straten E., Ralfiaer J.et al. T-cell receptor variable region genes in cutaneous T-cell lymphomas. Br. J. Dermatol. 138:1998;3-12.
14. Wolfe J., Chooback L., Finn D.et al. Large transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor. J. Clin. Oncol. 13:1995;1751-1757.
15. Pannetier C., Levraud J.P., Lim A.et al. The Immunoscope approach for the analysis of T cell repertoires. Oksenberg J.R. The antigen T-cell receptor: selected protocols and applications. 1998;287-325 Chapman and Hall, London.
16. Musette P., Even J., Dubertret L.et al. Nickoloff B. The immunoscope analysis of T lymphocytes infiltrating melanocytic tumors. 2001;Humanae Press, Ann Arbor, MI.
17. Bour H., Puisieux I., Even J.et al. T-cell repertoire analysis in chronic plaque psoriasis suggests an antigen-specific immune response. Human Immunol. 60:1999;665-676.
18. Mempel M., Flageul B., Suarez F.et al. Comparaison of the T-cell patterns in leprous and cutaneous sarcoid granulomas: presence of Valfa24-invariant NKT cells in T-cell reactive leprosy together with highly biased TCR Valfa repertoire. Am. J. Pathol. 157:2000;509-523.
19. Andreu G., Leon A., Heshmati F.et al. Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders. Transfus. Sci. 15:1994;443-454.
20. Jackow C.M., Cather J.C., Hearne V.et al. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive staphylococcus aureus, and oligoclonal T-cell receptor Vb gene expansion. Blood. 89:1997;32-40.
21. Gilks C.B., Ho V.C., Gascoyne R.D.et al. T-cell receptor variable region gene expression in cutaneous T-cell lymphoma. J. Cutan. Pathol. 19:1992;21-26.
22. Jack A.S., Boylston A.W., Carrel S.et al. Cutaneous T-cell lymphoma cells employ a restricted range of T-cell antigen receptor variable region receptor. Am. J. Pathol. 136:1990;17-21.
23. Musette P., Becquet D., Delarbre C.et al. Expansion of a recurrent. Vβ5.3+T cell population in newly diagnosed and untreated HLA-DR2 multiple sclerosis patient Proc. Natl. Acad. Sci. U.S.A. 93:1996;12461-12466.
24. Lim A., Baron V., Ferradini L.et al. Combination of MHC-peptide multimer based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human. CD8+T cell immune response J. Immunol. Methods. 261:2002;177-194.
25. Mc Henry P.M., Campbell I., Mackie R.M. Assessment of an anti-T-cell receptor variable region antibody panel in cutaneous T-cell lymphoma. Br. J. Dermatol. 130:1994;595-598.
26. Oziemsky M.A., Rockman S.P., Marks D.I.et al. Extracorporeal photochemotherapy in the treatment of cutaneous T-cell lymphoma. Int. J. Dermatol. 30:1991;814-817.
27. Weinberg J.M., Jaworsky C., Benoit B.M.et al. The clonal nature of Sezary cells. Blood. 86:1995;4257-4262.
28. Marks D.I., Rockman S.P., Oziemski M.A.et al. Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T cell lymphoma. J. Clin. Invest. 86:1990;2080-2085.